Skip to content
Screener

Bausch Health Companies BHC Other Income (Expense)

Other Income (Expense) at other companies

Bausch + Lomb logo
Bausch + LombBLCO
-$5M-150%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$331M-209%
Staar Surgical logo
Staar SurgicalSTAA
$239K-91.8%
Ardelyx logo
ArdelyxARDX
$2.04M+7.7%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
-$5.58M+25.6%
Journey Medical Corporation logo
Journey Medical CorporationDERM
-$738K+1.5%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.37B+11.7%
Enterprise value$21.83B-1.3%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossBeforeTax.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Interest income1011
Interest expense(402)(330)
Loss on extinguishment of debt(1)
Foreign exchange and other(11)(4)
Loss before income taxes(1,354)(47)
Provision for income taxes(77)(39)
Net loss(1,431)(86)
Net loss attributable to noncontrolling interest828

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's other income (expense)?
Bausch Health Companies (BHC) reported other income (expense) of -$11M in Q1 2026.
How has Bausch Health Companies's other income (expense) changed year-over-year?
Bausch Health Companies's other income (expense) decreased by 175.0% year-over-year, from -$4M to -$11M.
What is the long-term trend for Bausch Health Companies's other income (expense)?
Over 3 years (2022 to 2025), Bausch Health Companies's other income (expense) has grown at a 86.6% compound annual growth rate (CAGR), from -$8M to -$52M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Bausch Health Companies's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude